3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
25
Stomach Neoplasms
3
Triple Negative Breast Neoplasms
2
Neoplasm Metastasis
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Rectal Neoplasms
1
Neoplasms
1
Neoplasm, Residual
1
Metastatic Gastroesophageal Junction Adenocarcinoma
1
Metastatic Colorectal Adenocarcinoma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma
1
Hodgkin Disease
1
HER2-positive Colorectal Cancer
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Gastric Cancer Adenocarcinoma Metastatic
1
Esophageal Neoplasms
1
Colorectal Cancer Metastatic
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Breast Neoplasms
1
Advanced/Metastatic Solid Tumors
1
Advanced Solid Tumors
1
Advanced Malignancies
1
Advanced Colorectal Cancer
1
Interventions
Gemcitabine
113
130-nm albumin-bound paclitaxel
64
Albumin-Bound Paclitaxel
43
Fluorouracil
37
Magnetic Resonance Spectroscopy
35
pembrolizumab
34
Irinotecan
34
Taxes
33
Specimen Handling
33
Leucovorin
33
Oxaliplatin
31
Biopsy
22
Cyclophosphamide
21
Nivolumab
18
fludarabine
16
Radiosurgery
16
Cisplatin
16
Drug Therapy
15
Capecitabine
12
folfirinox
11
durvalumab
11
Radiotherapy
11
irinotecan sucrosofate
10
Ipilimumab
10
Cetuximab
10
Carboplatin
10
Blood Specimen Collection
10
olaparib
9
Standard of Care
9
dehydroftorafur
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pancreatic Neoplasms
×
HMPL-013
×
1 year
×
Clear all
No trials found.